Celldex Therapeutics Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

20.88

0.17 (0.82%)

At close: May 02, 2025, 3:02 PM

Celldex Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	28.36M	34.81M	29.43M	39.14M	43.84M	11.23M	24.31M	40.29M	42.46M
Short-Term Investments	696.92M	388.78M	275.52M	369.11M	150.59M	53.15M	69.71M	99.14M	147.31M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	1.8M	1.8M	n/a
Other Long-Term Assets	9.75M	107K	n/a	n/a	n/a	n/a	1.93M	1.93M	n/a
Receivables	700K	2.63M	347K	172K	1.8M	1.01M	3.16M	1.88M	1.78M
Inventory	n/a	n/a	-347K	-172K	-1.8M	-1.01M	-3.16M	n/a	-1.78M
Other Current Assets	21.18M	5.47M	12.39M	n/a	n/a	n/a	n/a	3.45M	n/a
Total Current Assets	747.16M	431.69M	317.69M	410.84M	197.84M	66.7M	99.08M	144.76M	195.57M
Property-Plant & Equipment	8.24M	6.64M	3.75M	3.55M	3.81M	4.03M	6.11M	10.37M	13.19M
Goodwill & Intangibles	27.19M	27.19M	31.3M	30.26M	34.18M	52.2M	50.62M	158.57M	174.6M
Total Long-Term Assets	45.18M	33.93M	35.04M	33.81M	37.99M	56.23M	56.73M	170.87M	187.79M
Total Assets	792.34M	465.63M	352.74M	444.65M	235.84M	122.93M	155.81M	315.62M	383.36M
Account Payables	3.27M	3.49M	3.34M	1.23M	1.05M	1.17M	1.07M	1.72M	1.74M
Deferred Revenue	n/a	n/a	n/a	12M	8.46M	6.5M	2.48M	12.89M	n/a
Short-Term Debt	1.45M	n/a	1.45M	1.75M	1.33M	1.94M	4.53M	6.57M	n/a
Other Current Liabilities	34.78M	3.99M	4.85M	-192K	4.39M	2.01M	2.61M	13.11M	26.35M
Total Current Liabilities	39.5M	31.13M	18.61M	16.53M	14.21M	11.64M	12.6M	27.74M	35.22M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.83M	4.4M	5.33M	7.35M	10.12M	15.55M	19.15M	51.52M	82.7M
Total Long-Term Liabilities	5.83M	5.33M	7.92M	8.65M	12.28M	17.26M	19.15M	51.52M	82.7M
Total Liabilities	45.34M	36.46M	26.53M	25.18M	26.48M	28.91M	31.75M	79.25M	117.93M
Total Debt	3.81M	2.54M	4.03M	3.04M	3.48M	3.66M	4.53M	6.57M	n/a
Common Stock	66K	56K	47K	47K	40K	17K	12K	139K	121K
Retained Earnings	-1.56B	-1.4B	-1.26B	-1.14B	-1.07B	-1.01B	-962.44M	-812.52M	-719.49M
Comprehensive Income	3.31M	3.31M	1.26M	1.89M	2.59M	2.62M	2.58M	2.56M	2.54M
Shareholders Equity	747M	429.17M	326.2M	419.48M	209.36M	94.03M	124.06M	236.37M	265.43M
Total Investments	696.92M	388.78M	275.52M	369.11M	150.59M	53.15M	69.71M	99.14M	147.31M